Working… Menu
Trial record 88 of 186 for:    GLYCOPYRROLATE

Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03346070
Recruitment Status : Completed
First Posted : November 17, 2017
Last Update Posted : April 19, 2019
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 29, 2019
Actual Study Completion Date : January 29, 2019